EUVIMEDEUVIMED entdecken
Crossref

Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries

Amir Ali Hamidieh, Maryam Behfar, Negar Nejati, Sadaf Setare Azar, Mohammad Taha Salmanifard Ardestani, Romana Malik, Homa Kashani, Rashin Mohseni, Leila Jafari

Immunology Letters · 2026

DOI: 10.1016/j.imlet.2025.107083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2026. Verfasst von Amir Ali Hamidieh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Granulomatous Disease, Chronic, BCG Vaccine, Hematopoietic Stem Cell Transplantation, Vaccination. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Recent advances in hematopoietic stem cell transplantation (HSCT) have improved clinical outcomes; however, various factors continue to influence HSCT success, especially vaccination in immunocompromised patients who receive vaccination at birth. While several studies have investigated the efficacy of vaccines in Chronic Granulomatous Disease (CGD) patients, the specific impact of vaccination on HSCT outcomes in these patients has not yet been studied. This study aimed to address an important gap in the current literature by investigating the effects of BCG vaccination on HSCT outcomes in patients with CGD. PARTICIPANTS AND METHODS: In this prospective study, 24 pediatric patients with CGD were enrolled from 2016 to 2022, all of whom received the same reduced-intensity conditioning (RIC) regimen before HSCT. Of these, 12 patients received the Bacillus Calmette-Guérin (BCG) vaccine, while 14 patients were not vaccinated. RESULTS: Contrary to other studies, our results showed that CGD patients who received the BCG vaccine before HSCT experienced varying degrees of BCGosis and BCGitis. Specifically, 8 patients showed symptoms of BCGosis, while 4 patients showed symptoms of BCGitis. In addition, our findings revealed no significant differences in graft-versus-host disease (GvHD) and other complications of HSCT between BCG-vaccinated and non-BCG-vaccinated CGD patients, although the overall survival (OS) rate was lower in the vaccinated group. This may be attributed to the reduced-intensity conditioning regimen applied to all patients which can balance HSCT outcome in CGD patients. DISCUSSION AND CONCLUSION: Our study emphasizes the importance of screening and diagnosing immunodeficient patients at birth, especially in developing countries where BCG vaccine is administered at birth, as post- vaccination complications can significantly affect HSCT outcomes and subsequent treatments. BCG vaccination can significantly affect HSCT outcomes and subsequent treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulomatous Disease, ChronicBCG VaccineHematopoietic Stem Cell TransplantationVaccinationHumansFemaleMaleChild, PreschoolChildInfantDeveloping CountriesProspective StudiesGraft vs Host DiseaseTransplantation ConditioningAdolescentTreatment Outcome

Stichwörter der Autor:innen

Bacillus Calmette– Guérin vaccineChronic granulomatous diseaseHematopoietic stem cell transplantationPediatric

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Research Methodology and Data Analysis, Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran.
  • Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: l.jafarie67@gmail.com.

Förderung

  • Tehran University of Medical Sciences

Zitieren

APA

Hamidieh, A. A., Behfar, M., Nejati, N., Azar, S. S., Salmanifard Ardestani, M. T., Malik, R., Kashani, H., Mohseni, R., & Jafari, L. (2026). Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.107083

Vancouver

Hamidieh AA, Behfar M, Nejati N, Azar SS, Salmanifard Ardestani MT, Malik R, et al. Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries. Immunology Letters. 2026. doi:10.1016/j.imlet.2025.107083

BibTeX
@article{Hamidieh2026,
  author = {Hamidieh, Amir Ali and Behfar, Maryam and Nejati, Negar and Azar, Sadaf Setare and Salmanifard Ardestani, Mohammad Taha and Malik, Romana and Kashani, Homa and Mohseni, Rashin and Jafari, Leila},
  title = {Importance of BCG Vaccination at birth in Pediatric Patients with Chronic Granulomatous Disease after Hematopoietic Stem Cell Transplantation in Developing Countries},
  journal = {Immunology Letters},
  year = {2026},
  doi = {10.1016/j.imlet.2025.107083}
}
Kostenlos starten →